Download PDF

Register to download the report. Already a member?

 
 
Sign Up

Or

63850 1504871583HCLSReviewHongKongSeptember2017.pdf
Energy Boardroom

Takeda Japan candesartan promotion, study under scrutiny

05.03.2014 / Scripintelligence

The company strongly denied any inappropriate access to data from the CASE-J investigator-initiated study or that it provided improper funding for this. However, it did acknowledge that some promotional activities included incomplete descriptions of…

LATEST ISSUE

DOWNLOAD

X
Download PDF

First Name:

Last Name:

Company:

Position:

Country:

Email: